Gemcitabine Hydrochloride Market Share

Market Share of Gemcitabine Hydrochloride Industry

The Gemcitabine Hydrochloride Market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Eli Lilly & Co., Accord Healthcare Inc., Pfizer Inc. (Hospira Inc.), Apotex Inc., Fresenius Kabi USA, Gland Pharma Ltd., Mylan Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Teva Pharmaceuticals Ltd., and Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Gemcitabine Hydrochloride Market Leaders

1. Eli Lilly & Co.

2. Apotex Inc.

3. Fressenius Kabi USA

4. Mylan Pharmaceuticals Inc.

5. Pfizer Inc. (Hospira Inc.)

*Disclaimer: Major Players sorted in no particular order